Want to see SXI full AI Analyst Report?
SXI Stock Chart & Stats
$278.40
$0.23(0.12%)
At close: 4:00 PM EST
$278.40
$0.23(0.12%)
Day’s Range― - ―
52-Week Range$152.64 - $344.30
Previous CloseN/A
Volume6.99K
Average Volume (3M)143.50K
Market Cap
$4.13B
Enterprise Value$4.00B
Total Cash (Recent Filing)$103.72M
Total Debt (Recent Filing)$521.90M
Price to Earnings (P/E)41.3
Beta1.08
Next Earnings
Jul 30, 2026EPS Estimate
2.35Next Dividend Ex-DateN/A
Dividend Yield0.57%
Share Statistics
EPS (TTM)8.24
Shares Outstanding12,114,922
10 Day Avg. Volume174,098
30 Day Avg. Volume143,496
Financial Highlights & Ratios
PEG Ratio-1.36
Price to Book (P/B)2.62
Price to Sales (P/S)2.36
P/FCF Ratio45.24
Enterprise Value/Market Cap0.97
Enterprise Value/Revenue4.52
Enterprise Value/Gross Profit11.35
Enterprise Value/Ebitda17.44
Forecast
1Y Price Target
$316.33Price Target Upside13.63% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)8.66
Revenue Forecast (FY)$889.85M
Bulls Say, Bears Say
Bulls Say
Strong Recent Revenue GrowthA large TTM revenue step-up indicates the company has materially expanded its scale and market traction, underpinning sustainable top-line momentum. Sustained higher revenue supports operating leverage, investment in new products and resilience across cycles, improving mid-term growth visibility.
Expanding New-product Pipeline & Fast-growth MixA sizeable new-product cadence and targeted $24–$64M incremental sales materially bolster organic growth and diversify revenue mix. Persistently higher new-product contribution can lift gross margins and reduce reliance on legacy lines, creating durable upside over the next several quarters.
Deleveraging And Improved LiquidityDebt paydown and substantial available liquidity strengthen financial flexibility and lower near-term refinancing risk. A leaner leverage profile (~1.9x net) supports continued M&A optionality, dividend consistency and capital investment while reducing interest-cost sensitivity to shocks.
Bears Say
Weak Cash ConversionOperating cash flow lagging net income signals earnings are not fully converting to cash, reducing internal funding for capex, debt reduction and acquisitions. Persistently weak cash conversion increases dependence on external financing and makes financial performance more volatile across cycles.
Elevated Leverage Versus Prior YearsHigher leverage relative to recent history raises financial risk and interest exposure, constraining strategic flexibility. Even after improvement, elevated debt levels can limit ability to pursue large acquisitions or absorb downturns and make cash flow variability more consequential.
Dependence On Government And Cyclical End MarketsMaterial upside hinging on government procurement and exposure to academic/research funding creates timing and visibility risk. Revenues tied to multi-year contracts or government budgets can be lumpy, making near- to mid-term growth sensitive to policy, budget cycles and award timing.
Standex International News
SXI FAQ
What was Standex International’s price range in the past 12 months?
Standex International lowest stock price was $152.64 and its highest was $344.30 in the past 12 months.
What is Standex International’s market cap?
Standex International’s market cap is $4.13B.
When is Standex International’s upcoming earnings report date?
Standex International’s upcoming earnings report date is Jul 30, 2026 which is in 31 days.
How were Standex International’s earnings last quarter?
Standex International released its earnings results on Apr 30, 2026. The company reported $2.21 earnings per share for the quarter, missing the consensus estimate of $2.216 by -$0.006.
Is Standex International overvalued?
According to Wall Street analysts Standex International’s price is currently Undervalued.
Does Standex International pay dividends?
Standex International pays a Quarterly dividend of $0.34 which represents an annual dividend yield of 0.57%. See more information on Standex International dividends here
What is Standex International’s EPS estimate?
Standex International’s EPS estimate is 2.35.
How many shares outstanding does Standex International have?
Standex International has 12,114,922 shares outstanding.
What happened to Standex International’s price movement after its last earnings report?
Standex International reported an EPS of $2.21 in its last earnings report, missing expectations of $2.216. Following the earnings report the stock price went down -8.927%.
Which hedge fund is a major shareholder of Standex International?
Currently, no hedge funds are holding shares in SXI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Standex International Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$316.33 (13.63% Upside)
$316.33 (13.63% Upside)
Blogger Sentiment
Neutral
SXI Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 14.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $153.3K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
19.37%
12-Months-Change
Fundamentals
Return on Equity
13.78%
Trailing 12-Months
Asset Growth
-1.79%
Trailing 12-Months
Company Description
Standex International
Standex International Corporation (SXI) operates as a diversified global manufacturer and provider of products and services, catering to commercial and industrial markets across the United States and internationally. The company's operations are strategically organized into five key segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions. The Electronics division specializes in a wide array of sensors, including reed relays, fluid level, proximity, motion, flow, and HVAC condensate, along with custom electronic sensing solutions. It also delivers cutting-edge current sense and advanced planar transformer technologies, value-added assemblies, mechanical packaging, and bespoke wound transformers and inductors for both low and high-frequency applications. The Engraving segment offers mold texturizing, produces slush molding tools, provides roll engraving, and manufactures tooling for hygiene products and low observation vents. Additionally, it supplies project management and design services tailored for stealth aircraft, alongside process machinery for various industries. Within the Scientific segment, Standex develops and supplies temperature-controlled equipment, serving the medical, scientific, pharmaceutical, biotechnology, and broader industrial sectors. The Engineering Technologies segment is dedicated to providing comprehensive, customized net and near-net formed solutions for engineered components. These critical components are utilized across a wide spectrum of markets, including aviation, aerospace, defense, energy, industrial, medical, marine, oil and gas, and both manned and unmanned space applications. Finally, the Specialty Solutions segment focuses on the manufacturing and distribution of refrigerated, heated, and dry merchandising display cases. It also provides custom fluid pump solutions and produces single and double-acting telescopic and piston rod hydraulic cylinders. Established in 1955, Standex International Corporation maintains its headquarters in Salem, New Hampshire.
SXI Company Deck
SXI Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed predominantly positive operational and financial momentum: strong top‑line growth (8.1% overall), record Electronics revenue, robust Aerospace & Defense expansion, accelerating new product sales (≈40% growth) and meaningful balance sheet improvement via the Federal divestiture and $62 million debt paydown. Offsetting items are modest: margin compression in parts of Electronics and Aerospace & Defense due to growth investments, a small revenue decline in Scientific tied to NIH cuts, organic softness in Hydraulics, and increased near‑term capex and operating cost investments. Overall, the positives (revenue growth, product pipeline, book‑to‑bill >1, debt reduction, improved EPS and FCF) materially outweigh the contained challenges and investments.View all SXI earnings summariesSXI Stock 12 Month Forecast
Average Price Target
$316.33
▲(13.63% Upside)
Technical Analysis
Ownership Overview
1.82% Insiders
40.95% Mutual Funds
25.65% Other Institutional Investors
4.47% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---